Welcome to Virtual ILC 2021

June 24th-25th, 2021

The International ILC Virtual Symposium will be an opportunity for physicians, researchers, patient advocates and organizations who are interested in learning about ILC and the most current research, to come together to better understand this disease. We believe that this symposium will be an opportunity to share current research in ILC and continue to build a vibrant and collaborative community of physicians, researchers and advocates that ultimately impacts the outcome for patients with ILC.  Visit ilcsymposium.com for more information.

Patient Advocate Special Sessions

12:00pm-1:30pm EDT

Orientation: June 23rd, 2021

Highlights Discussion: June 30th, 2021

Scientific Sessions

9:00am-2:30pm EDT

Day 1: June 24th, 2021

Day 2: June 25th, 2021

We look forward to seeing everyone at the in-person symposium scheduled for 2022 in Europe. 

Co-Chairs:

Steffi Oesterreich, PhD

Professor, Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA

Co-Leader, Cancer Biology Program, UPMC Hillman Cancer Center

Co-Director of the Women's Cancer Research Center

Magee-Womens Research Institute

Otto Metzger, MD

Medical Oncologist, Dana-Farber Cancer Institute

Executive Officer, Alliance for Clinical Trials in Oncology

Harvard Medical School, Boston, MA

Christine Desmedt, PhD

Head of Laboratory for Translational Breast Cancer Research

Department of Oncology, KU Leuven, Leuven, Belgium

Patrick W.B. Derksen, PhD

Professor, University Medical Center (UMC) Utrecht, Utrecht, Netherlands